Literature DB >> 7275186

Studies on the possible involvement of complement component C3 in the initiation of acid hydrolase secretion by macrophages. I. Correlation between enzyme-releasing and complement-activating capacities of several secretagogues.

D W Riches, D R Stanworth.   

Abstract

A possible relationship between activation of the alternative pathway of complement and acid hydrolase secretion by macrophages has been investigated in vitro by examining the dose--response characteristics of several immunological and non-immunological stimuli of these two processes. Zymosan particles, insoluble immune complexes, methylamine and several other primary aliphatic monoamines were all found to elicit the selective release of lysosomal enzymes from macrophages by a process that correlated well with the ability of these agents to bring about consumption of haemolytically-active components of the alternative complement pathway. By contrast, substances which failed to activate the alternative complement pathway, i.e. soluble aggregated immunoglobulin and several primary aliphatic diamines, were found to be likewise incapable of inducing the selective release of lysosomal glycosidases from macrophages. These observations are interpreted as further evidence for imputing a role for complement C3 in the initiation of lysosomal enzyme release from macrophages.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7275186      PMCID: PMC1555105     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  16 in total

1.  Synthesis of factors D, B and P of the alternative pathway of complement activation, as well as of C3, by guinea-pig peritoneal macrophages in vitro.

Authors:  C Bentley; W Fries; V Brade
Journal:  Immunology       Date:  1978-12       Impact factor: 7.397

2.  The Action of Ammonia on Complement. The Fourth Component.

Authors:  J Gordon; H R Whitehead; A Wormall
Journal:  Biochem J       Date:  1926       Impact factor: 3.857

3.  Chemotactic response to human C3a and C5a anaphylatoxins. I. Evaluation of C3a and C5a leukotaxis in vitro and under stimulated in vivo conditions.

Authors:  H N Fernandez; P M Henson; A Otani; T E Hugli
Journal:  J Immunol       Date:  1978-01       Impact factor: 5.422

4.  Complement activation by the alternative pathway and macrophage enzyme secretion in the pathogenesis of chronic inflammation.

Authors:  H U Schorlemmer; D Bitter-Suermann; A C Allison
Journal:  Immunology       Date:  1977-06       Impact factor: 7.397

5.  Effect of cyclic AMP on release of lysosomal enzymes from phagocytes.

Authors:  G Weissmann; P Dukor; R B Zurier
Journal:  Nat New Biol       Date:  1971-06-02

6.  Bypass-activation of the complement system starting with C3. II. C3-activation by gamma-1-immune aggregates in guinea pig serum.

Authors:  W König; D Bitter-Suermann; M Dierich; U Hadding
Journal:  Immunochemistry       Date:  1973-07

7.  The reaction of zymosan with the properdin system in normal and C4-deficienct guinea pig serum. Demonstration of C3- and C5-cleaving multi-unit enzymes, both containing factor B, and acceleration of their formation by the classical complement pathway.

Authors:  V Brade; G D Lee; A Nicholson; H S Shin; M M Mayer
Journal:  J Immunol       Date:  1973-11       Impact factor: 5.422

8.  Factor B of the alternative complement pathway on human lymphocytes.

Authors:  L Halbwachs; P J Lachmann
Journal:  Scand J Immunol       Date:  1976       Impact factor: 3.487

9.  Anaphylatoxin-induced histamine release with human leukocytes: studies of C3a leukocyte binding and histamine release.

Authors:  M M Glovsky; T E Hugli; T Ishizaka; L M Lichtenstein; B W Erickson
Journal:  J Clin Invest       Date:  1979-09       Impact factor: 14.808

10.  Primary amines induce selective release of lysosomal enzymes from mouse macrophages.

Authors:  D W Riches; D R Stanworth
Journal:  Biochem J       Date:  1980-06-15       Impact factor: 3.857

View more
  10 in total

1.  IgA-alpha 1 antitrypsin complexes in ankylosing spondylitis.

Authors:  G R Struthers; I V Lewin; D R Stanworth
Journal:  Ann Rheum Dis       Date:  1989-01       Impact factor: 19.103

2.  Stimulation of complement component C3 synthesis in macrophagelike cell lines by group B streptococci.

Authors:  K J Goodrum
Journal:  Infect Immun       Date:  1987-05       Impact factor: 3.441

Review 3.  Regulation of immune response by components of the complement cascade and their activated fragments.

Authors:  W O Weigle; M G Goodman; E L Morgan; T E Hugli
Journal:  Springer Semin Immunopathol       Date:  1983

4.  Biochemical differences in the mechanism of macrophage lysosomal exocytosis initiated by zymosan particles and weak bases.

Authors:  D W Riches; J L Watkins; D R Stanworth
Journal:  Biochem J       Date:  1983-06-15       Impact factor: 3.857

5.  The capacity of basic peptides to trigger exocytosis from mast cells correlates with their capacity to immobilize band 3 proteins in erythrocyte membranes.

Authors:  M J Dufton; R J Cherry; J W Coleman; D R Stanworth
Journal:  Biochem J       Date:  1984-10-01       Impact factor: 3.857

6.  Evidence for a mechanism for the initiation of acid hydrolase secretion by macrophages that is functionally independent of alternative pathway complement activation.

Authors:  D W Riches; D R Stanworth
Journal:  Biochem J       Date:  1982-03-15       Impact factor: 3.857

7.  Ebola virus infection in guinea pigs: presumable role of granulomatous inflammation in pathogenesis.

Authors:  E Ryabchikova; L Kolesnikova; M Smolina; V Tkachev; L Pereboeva; S Baranova; A Grazhdantseva; Y Rassadkin
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

8.  Opsonin-independent phagocytosis of group B streptococci: role of complement receptor type three.

Authors:  J M Antal; J V Cunningham; K J Goodrum
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

9.  Tissue localization of complement component 3 receptor-bearing cells in lymphoid tissue after injection with complete Freund adjuvant.

Authors:  H Okuyama; S Kobayashi; M Fujita; R Yasumizu; K Morikawa
Journal:  Infect Immun       Date:  1982-11       Impact factor: 3.441

10.  High levels of complement breakdown products in tuberculous pleural effusions.

Authors:  D P Lew; L H Perrin; J D Vassalli; S Suter; P H Lambert; F A Waldvogel
Journal:  Clin Exp Immunol       Date:  1983-06       Impact factor: 4.330

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.